Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Thalassemia × Busulfan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma 8 Leukemia 8 Myelodysplastic Syndromes 6 Multiple Myeloma 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Recurrence 5 Lymphoma, Follicular 5 Hodgkin Disease 5 Congenital Abnormalities 5 Blast Crisis 5 Primary Myelofibrosis 4 Myeloproliferative Disorders 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myeloid, Accelerated Phase 4 Pdgfra-Associated Chronic Eosinophilic Leukemia 3 Neoplasms, Plasma Cell 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Neutrophilic, Chronic 3 Leukemia, Myelomonocytic, Juvenile 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Graft vs Host Disease 3

Interventions

fludarabine phosphate 1 fludarabine 1 Mesna 1 Cyclophosphamide 1 Busulfan 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡